ACCE, pharmacogenomics, and stopping clinical trials: time to extend the CONSORT statement?
- PMID: 21400375
- DOI: 10.1080/15265161.2010.546477
ACCE, pharmacogenomics, and stopping clinical trials: time to extend the CONSORT statement?
Comment on
-
Inefficacy interim monitoring procedures in randomized clinical trials: the need to report.Am J Bioeth. 2011 Mar;11(3):2-10. doi: 10.1080/15265161.2010.546471. Am J Bioeth. 2011. PMID: 21400374
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical